Consultation
Target crop, claim to be substantiated, timeline, regulatory context and commercial constraints.
Technology validation
We help companies generate credible scientific evidence to support commercialisation, fundraising and regulatory submission — evidence built to hold up when a due-diligence team pulls it apart.
The problem we solve
Most agricultural technologies arrive at market with an evidence base generated by the company selling them. That data may be perfectly sound. It is also, structurally, the weakest possible position from which to answer a sceptical buyer, a regulator or an investment committee.
The question is never only what does the data show. It is who generated it, under what design, and what would have happened if the result had been unfavourable. An independent trial answers all three at once.
Evidence generated by a party with nothing to gain is worth more than the same evidence generated by a party with everything to gain.
That is the entire proposition. Everything below is the machinery for delivering it.
Services
Each is available on its own or as a stage within a longer programme. Every engagement, however small, is delivered under the same design and reporting standards.
A short, contained first look. Small plot count, tight endpoint set, designed to tell you whether a full programme is justified before you commit a season and a budget to it. Typically 8–12 weeks.
Deliverable · Go / no-go decision memo
The first properly powered demonstration that an effect exists under field conditions. Replicated, randomised, concurrently controlled, with the effect size and its confidence interval as the headline output.
Deliverable · Technical report with raw data
Multi-block, multi-cultivar or multi-site execution of a design that has already shown effect. Built to withstand the scrutiny a regulatory submission or an acquisition attracts.
Deliverable · Full study report and analysis file
Your candidate run head-to-head against named competitor products or a conventional reference standard, under identical management, in the same block, in the same season.
Deliverable · Comparative performance report
Design of the analysis plan, power calculation, execution of the analysis and production of publication-grade figures. Available as a standalone service for data generated elsewhere.
Deliverable · Analysis script and figure set
Protocol architecture for trials you will run yourself or at other sites: plot layout, randomisation scheme, replication, endpoint definition and measurement schedule.
Deliverable · Signed protocol document
Standard operating procedures for a technology that will be trialled repeatedly, so that results from different seasons and different sites remain comparable.
Deliverable · SOP library
Independent confirmation that a product performs as its existing documentation claims — commonly required by distributors, retailers and certification bodies.
Deliverable · Verification statement
Standing demonstration plots timed and laid out for site visits, with the comparison visible to a non-specialist and the underlying data available to a specialist.
Deliverable · Site visit programme
Independent examination of whether an existing evidence base supports the claims made for a technology. Commissioned by investors, acquirers and licensing partners.
Deliverable · Due diligence assessment
Larger visual plots for grower days, distributor training and sales enablement, held to the same measurement discipline as research plots.
Deliverable · Demonstration plot and data pack
Trials designed from the outset against the evidence requirements of the dossier or claim you are preparing, rather than retrofitted to them afterwards.
Deliverable · Dossier-ready data package
Multi-season, multi-objective programmes for organisations that need a continuing field research capability without building one.
Deliverable · Annual programme agreement
Manuscript preparation, conference posters, technical bulletins and claim wording grounded in what the data actually supports.
Deliverable · Publication-ready materials
Process
Eight stages, each with a defined output and a sign-off point. You know what you are receiving, and when, before the season begins.
Target crop, claim to be substantiated, timeline, regulatory context and commercial constraints.
Replication, randomisation, control strategy and statistical power fixed before anything is sown.
Written protocol signed by both parties and locked for the duration of the trial.
Plots established, arms blinded where feasible, applications logged against date, dose and volume.
Scheduled measurement rounds with photographic record and weather correlation throughout.
Effect sizes, significance testing and variance interrogated before any interpretation is written.
Publication-grade write-up with methods, figures, raw data, deviations and stated limitations.
Where evidence supports it: next-stage design, defensible claim wording and dossier positioning.
Planning
Actual figures depend on crop, endpoint and season. These are the ranges we work within, given so you can plan a funding round or a launch against something real.
| Engagement | Duration | Plots | Primary output |
|---|---|---|---|
| Pilot trial | 8–12 weeks | 8–16 | Go / no-go decision memo |
| Proof of concept | 1 season | 24–48 | Technical report with effect sizes |
| Large-scale validation | 1–2 seasons | 60–120 | Full study report and analysis file |
| Product benchmarking | 1 season | 32–64 | Comparative performance report |
| Multi-site network | 1–3 seasons | Per site | Multi-environment analysis |
| Due diligence | 3–6 weeks | Desk-based | Independent assessment |
Common questions
You do. Raw measurements, analysis files and photographs are delivered to you and are yours to use. We retain the right to state that a trial was conducted, and to reference the design in our methodological publications, without disclosing your results.
You can terminate the contract at any point. What you cannot do is have an incomplete trial reported as though it had run to completion, or have unfavourable arms removed from a report we put our name to. Terminated trials are reported as terminated.
Yes, as standard, covering formulation, composition and results. Confidentiality over your data is entirely compatible with independence over its interpretation.
Yes, and it should be. Tell us the framework you are submitting under at the consultation stage. Retrofitting a completed trial to an evidence requirement it was not designed for is the most common and most expensive mistake we see.
Loss conditions and remedies are agreed in the contract before the season. Where a block is lost to an extreme event, the affected plots are reported as lost with the cause recorded, and the remaining analysis is reported with its reduced power stated plainly.
Regularly. A well-designed pilot is often the single most valuable item a seed-stage company can put in front of an investor, and it costs considerably less than a full validation programme. Start with the pilot.
Get started
Describe the product, the crop and the decision the evidence has to support. You will get a proposed design, a duration and a cost — usually within five working days.